|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zeng H, Zheng R, Guo Y, Zhang S, Zou X,
Wang N, Zhang L, Tang J, Chen J, Wei K, et al: Cancer survival in
China, 2003–2005: A population-based study. Int J Cancer.
136:1921–1930. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Whiteside TL: The tumor microenvironment
and its role in promoting tumor growth. Oncogene. 27:5904–5912.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee CH, Liu SY, Chou KC, Yeh CT, Shiah SG,
Huang RY, Cheng JC, Yen CY and Shieh YS: Tumor-associated
macrophages promote oral cancer progression through activation of
the Axl signaling pathway. Ann Surg Oncol. 21:1031–1037. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and metastasis. Nat Med.
19:1423–1437. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Joyce JA and Pollard JW:
Microenvironmental regulation of metastasis. Nat Rev Cancer.
9:239–252. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fan QM, Jing YY, Yu GF, Kou XR, Ye F, Gao
L, Li R, Zhao QD, Yang Y, Lu ZH, et al: Tumor-associated
macrophages promote cancer stem cell-like properties via
transforming growth factor-beta1-induced epithelial-mesenchymal
transition in hepatocellular carcinoma. Cancer Lett. 352:160–168.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu Y, He MY, Zhu LF, Yang CC, Zhou ML,
Wang Q, Zhang W, Zheng YY, Wang DM, Xu ZQ, et al: Tumor-associated
macrophages correlate with the clinicopathological features and
poor outcomes via inducing epithelial to mesenchymal transition in
oral squamous cell carcinoma. J Exp Clin Cancer Res. 35:122016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang BC, Gao J, Wang J, Rao ZG, Wang BC
and Gao JF: Tumor-associated macrophages infiltration is associated
with peritumoral lymphangiogenesis and poor prognosis in lung
adenocarcinoma. Med Oncol. 28:1447–1452. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Suriano F, Santini D, Perrone G, Amato M,
Vincenzi B, Tonini G, Muda A, Boggia S, Buscarini M and Pantano F:
Tumor associated macrophages polarization dictates the efficacy of
BCG instillation in non-muscle invasive urothelial bladder cancer.
J Exp Clin Cancer Res. 32:872013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yan Y, Zhang J, Li JH, Liu X, Wang JZ, Qu
HY, Wang JS and Duan XY: High tumor-associated macrophages
infiltration is associated with poor prognosis and may contribute
to the phenomenon of epithelial-mesenchymal transition in gastric
cancer. Onco Targets Ther. 9:3975–3983. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mei J, Xiao Z, Guo C, Pu Q, Ma L, Liu C,
Lin F, Liao H, You Z and Liu L: Prognostic impact of
tumor-associated macrophage infiltration in non-small cell lung
cancer: A systemic review and meta-analysis. Oncotarget.
7:34217–34228. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang J, Yan Y, Yang Y, Wang L, Li M and
Wang J, Liu X, Duan X and Wang J: High infiltration of
tumor-associated macrophages influences poor prognosis in human
gastric cancer patients, associates with the phenomenon of EMT.
Medicine. 95:e26362016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang H, Wang X, Shen Z, Xu J, Qin J and
Sun Y: Infiltration of diametrically polarized macrophages predicts
overall survival of patients with gastric cancer after surgical
resection. Gastric Cancer. 18:740–750. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bonde AK, Tischler V, Kumar S, Soltermann
A and Schwendener RA: Intratumoral macrophages contribute to
epithelial-mesenchymal transition in solid tumors. BMC Cancer.
12:352012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu CY, Xu JY, Shi XY, Huang W, Ruan TY,
Xie P and Ding JL: M2-polarized tumor-associated macrophages
promoted epithelial-mesenchymal transition in pancreatic cancer
cells, partially through TLR4/IL-10 signaling pathway. Lab Invest.
93:844–854. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ravi J, Elbaz M, Wani NA, Nasser MW and
Ganju RK: Cannabinoid receptor-2 agonist inhibits macrophage
induced EMT in non-small cell lung cancer by downregulation of EGFR
pathway. Mol Carcinog. 55:2063–2076. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Deng YR, Liu WB, Lian ZX, Li X and Hou X:
Sorafenib inhibits macrophage-mediated epithelial-mesenchymal
transition in hepatocellular carcinoma. Oncotarget. 7:38292–38305.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Su S, Liu Q, Chen J, Chen J, Chen F, He C,
Huang D, Wu W, Lin L, Huang W, et al: A positive feedback loop
between mesenchymal-like cancer cells and macrophages is essential
to breast cancer metastasis. Cancer Cell. 25:605–620. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Techasen A, Loilome W, Namwat N, Dokduang
H, Jongthawin J and Yongvanit P: Cytokines released from activated
human macrophages induce epithelial mesenchymal transition markers
of cholangiocarcinoma cells. Asian Pac J Cancer Prev. 13
(Suppl):115–118. 2012.PubMed/NCBI
|
|
23
|
Zhang J, Yao H, Song G, Liao X, Xian Y and
Li W: Regulation of epithelial-mesenchymal transition by
tumor-associated macrophages in cancer. Am J Transl Res.
7:1699–1711. 2015.PubMed/NCBI
|
|
24
|
Zhang M, Xu Q, Yan S, Li Z, Yan W and Jia
X: Suppression of forkhead box Q1 by microRNA-506 represses the
proliferation and epithelial-mesenchymal transition of cervical
cancer cells. Oncol Rep. 35:3106–3114. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qiao Y, Jiang X, Lee ST, Karuturi RK, Hooi
SC and Yu Q: FOXQ1 regulates epithelial-mesenchymal transition in
human cancers. Cancer Res. 71:3076–3086. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang H, Meng F, Liu G, Zhang B, Zhu J, Wu
F, Ethier SP, Miller F and Wu G: Forkhead transcription factor
foxq1 promotes epithelial-mesenchymal transition and breast
cancer metastasis. Cancer Res. 71:1292–1301. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Feng J, Zhang X, Zhu H, Wang X, Ni S and
Huang J: FoxQ1 overexpression influences poor prognosis in
non-small cell lung cancer, associates with the phenomenon of EMT.
PLoS One. 7:e399372012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu Z, Zhu Z, Pang Z, Xing Y, Wan F, Lan D
and Wang H: Short hairpin RNA targeting FOXQ1 inhibits invasion and
metastasis via the reversal of epithelial-mesenchymal transition in
bladder cancer. Int J Oncol. 42:1271–1278. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sehrawat A, Kim SH, Vogt A and Singh SV:
Suppression of FOXQ1 in benzyl isothiocyanate-mediated inhibition
of epithelial-mesenchymal transition in human breast cancer cells.
Carcinogenesis. 34:864–873. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Feng J, Xu L, Ni S, Gu J, Zhu H, Wang H,
Zhang S, Zhang W and Huang J: Involvement of FoxQ1 in NSCLC through
regulating EMT and increasing chemosensitivity. Oncotarget.
5:9689–9702. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fan DM, Feng XS, Qi PW and Chen YW:
Forkhead factor FOXQ1 promotes TGF-β1 expression and induces
epithelial-mesenchymal transition. Mol Cell Biochem. 397:179–186.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang J, Liu Y, Zhang J, Cui X, Li G, Wang
J, Ren H and Zhang Y: FOXQ1 promotes gastric cancer metastasis
through upregulation of Snail. Oncol Rep. 35:3607–3613. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xiang XJ, Deng J, Liu YW, Wan LY, Feng M,
Chen J and Xiong JP: MiR-1271 inhibits cell proliferation, invasion
and EMT in gastric cancer by targeting FOXQ1. Cell Physiol Biochem.
36:1382–1394. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Myatt SS and Lam EW: The emerging roles of
forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 7:847–859.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Feuerborn A, Srivastava PK, Küffer S,
Grandy WA, Sijmonsma TP, Gretz N, Brors B and Gröne HJ: The
Forkhead factor FoxQ1 influences epithelial differentiation. J Cell
Physiol. 226:710–719. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Eijkelenboom A and Burgering BM: FOXOs:
Signalling integrators for homeostasis maintenance. Nat Rev Mol
Cell Biol. 14:83–97. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jonsson H and Peng SL: Forkhead
transcription factors in immunology. Cell Mol Life Sci. 62:397–409.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Goering W, Adham IM, Pasche B, Manner J,
Ochs M, Engel W and Zoll B: Impairment of gastric acid secretion
and increase of embryonic lethality in Foxq1-deficient mice.
Cytogenet Genome Res. 121:88–95. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hong HK, Noveroske JK, Headon DJ, Liu T,
Sy MS, Justice MJ and Chakravarti A: The winged helix/forkhead
transcription factor Foxq1 regulates differentiation of hair
in satin mice. Genesis. 29:163–171. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Potter CS, Peterson RL, Barth JL, Pruett
ND, Jacobs DF, Kern MJ, Argraves WS, Sundberg JP and Awgulewitsch
A: Evidence that the satin hair mutant gene Foxq1 is among
multiple and functionally diverse regulatory targets for
Hoxc13 during hair follicle differentiation. J Biol Chem.
281:29245–29255. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kaneda H, Arao T, Tanaka K, Tamura D,
Aomatsu K, Kudo K, Sakai K, De Velasco MA, Matsumoto K, Fujita Y,
et al: FOXQ1 is overexpressed in colorectal cancer and enhances
tumorigenicity and tumor growth. Cancer Res. 70:2053–2063. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang W, He S, Ji J, Huang J, Zhang S and
Zhang Y: The prognostic significance of FOXQ1 oncogene
overexpression in human hepatocellular carcinoma. Pathol Res Pract.
209:353–358. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xia L, Huang W, Tian D, Zhang L, Qi X,
Chen Z, Shang X, Nie Y and Wu K: Forkhead box Q1 promotes
hepatocellular carcinoma metastasis by transactivating ZEB2 and
VersicanV1 expression. Hepatology. 59:958–973. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Pei Y, Wang P, Liu H, He F and Ming L:
FOXQ1 promotes esophageal cancer proliferation and metastasis by
negatively modulating CDH1. Biomed Pharmacother. 74:89–94. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Peng X, Luo Z, Kang Q, Deng D, Wang Q,
Peng H, Wang S and Wei Z: FOXQ1 mediates the crosstalk between
TGF-β and Wnt signaling pathways in the progression of colorectal
cancer. Cancer Biol Ther. 16:1099–1109. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liang SH, Yan XZ, Wang BL, Jin HF, Yao LP,
Li YN, Chen M, Nie YZ, Wang X, Guo XG, et al: Increased expression
of FOXQ1 is a prognostic marker for patients with gastric cancer.
Tumour Biol. 34:2605–2609. 2013. View Article : Google Scholar : PubMed/NCBI
|
